Page last updated: 2024-10-28
ibudilast and Glaucoma
ibudilast has been researched along with Glaucoma in 1 studies
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide." | 5.43 | The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. ( Belforte, N; Cueva Vargas, JL; Di Polo, A, 2016) |
| "Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide." | 1.43 | The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling. ( Belforte, N; Cueva Vargas, JL; Di Polo, A, 2016) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Cueva Vargas, JL | 1 |
| Belforte, N | 1 |
| Di Polo, A | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Uncovering Inflammatory Mediators of Glaucoma Pathogenesis After Corneal Transplantation in Aqueous Humor and Tears[NCT04339907] | | 200 participants (Anticipated) | Interventional | 2020-05-11 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for ibudilast and Glaucoma